A Single Centre, Phase I, Double-blind, Randomised, Placebo-controlled Study to Investigate the Safety, Tolerability, Pharmacokinetic Profile and Effects on EEG of Single Rising Oral Doses of BIA 2-093
Clinical trial NCT02171195 · COMPLETED
Trial details
- NCT number
- NCT02171195
- Sponsor
- Bial - Portela C S.A.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2000-07-01
- Primary completion
- 2000-10-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.